Gene Editing

Companies Produce First Genetically Engineered Porcine Donors

February 16, 2024 - On February 13, 2024, eGenesis, a United States-based biotechnology company, and PorMedTec, a Japanese porcine embryology organization, announced positive results of their collaboration, which produced the first successful genetically engineered porcine donors for xenotransplantation. “Production of our first donors outside the United States...

Read More


More Articles

CRISPR Treatment in Clinical Trial for Pediatric Sickle Cell Disease

by Veronica Salib

The European Hematology Association (EHA) recently released results from a clinical trial that implied the potential benefits of using CRISPR treatment to address pediatric sickle cell disease (SCD)....

Thermo Fisher Launches Cas-9 Protein to Support Genome Editing

by Samantha McGrail

Thermo Fisher Scientific recently introduced the GMP-manufactured Gibco CTS TrueCut Cas9 Protein to help researchers meet stringent quality requirements when using genome editing...

Mount Sinai Develops CRISPR Technology to Advance Cancer Treatment

by Samantha McGrail

Mount Sinai scientists recently developed CRISPR technology to link genes to complex tumor characteristics at a scale and resolution not previously possible.  Perturb-map CRISPR technology uses a...

Recent Articles